+724.4%
MRNA vs AMDL
+129.4%
+595.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AMDL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -15.5% | +16.8% | +2.7% |
| 7D | -13.8% | -31.9% | +18.1% | -11.1% |
| 30D | -17.7% | -28.0% | +10.3% | -16.9% |
| 3M | +14.3% | -11.4% | +25.7% | +13.7% |
| 6M | +336.0% | -6.9% | +342.8% | +299.5% |
| YTD | +575.9% | +174.4% | +401.5% | +344.7% |
| 1Y | +724.4% | +142.6% | +581.8% | +447.1% |
| All | +724.4% | +129.4% | +595.0% | +447.1% |
Cumulative growth
Daily Returns
Daily percentage return beside AMDL.
Daily Out/Under-Performance
Portfolio return minus AMDL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMDL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AMDL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling